Recent medical research identifies the LRPPRC in glioma as a significant driver of tumor progression. Specifically, the leucine-rich pentatricopeptide repeat-containing protein (LRPPRC) serves as an N6-methyladenosine (m6A) reader. Consequently, high levels of this protein appear in both glioma tissues and cell lines. Therefore, researchers are exploring how it influences metabolic reprogramming to sustain cancer growth.

The GATA3 Regulatory Axis

Furthermore, evidence shows that GATA-binding protein 3 (GATA3) transcriptionally regulates LRPPRC. GATA3 binds directly to the LRPPRC promoter to increase its production. Moreover, this protein then mediates the m6A modification of protocadherin-7 (PCDH7). However, silencing LRPPRC can reverse these oncogenic effects. Thus, inhibiting this specific pathway offers a promising strategy for neuro-oncology.

Impact of LRPPRC in Glioma on Cell Death

Additionally, the GATA3/LRPPRC/PCDH7 axis controls two crucial biological processes: glycolysis and ferroptosis. While LRPPRC promotes glycolysis to fuel tumor growth, it also prevents ferroptosis. Consequently, silencing LRPPRC induces iron-dependent cell death in glioma cells. Finally, in vivo data confirm that targeting this protein effectively reduces tumor size and suppresses further growth.

What is the role of LRPPRC in glioma?

LRPPRC acts as an m6A reader protein that stabilizes specific mRNAs like PCDH7. This stabilization promotes tumor growth by enhancing glycolysis and preventing ferroptosis.

How does GATA3 influence glioma development?

GATA3 is a transcription factor that directly stimulates the production of LRPPRC. This increase in LRPPRC levels fuels metabolic pathways that allow glioma cells to survive and proliferate.

Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

Sun Y et al. Leucine-rich pentatricopeptide repeat-containing protein silencing transcriptionally regulated by GATA-binding protein 3 has an anti-glioma effect by regulating glycolysis and ferroptosis by mediating N6-methyladenosine modification of protocadherin-7. J Neuropathol Exp Neurol. 2026 May 04. doi: undefined. PMID: 42081257.

Wang J et al. The m6A Reader LRPPRC Promotes Cancer Progression by Regulating Metabolic Pathways. Frontiers in Oncology. 2024.

Liu H et al. Deciphering the Link: Ferroptosis and its Role in Glioma. Frontiers in Cell and Developmental Biology. 2023.